Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen - Wikidata - wikimedia - TriplyDB

Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen

Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen

http://www.wikidata.org/entity/Q34764532

about

The Divergent CD8+ T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits.Classification of Laser Vaccine Adjuvants Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

P2860

Q35840727-C61BB5CA-EE43-45D9-9265-06A254AFE216 Q35996738-8005CA23-1BFD-4F7E-A46D-F3501F6507DE Q36316776-60EC293B-0B04-48AA-B00E-9BCBD8556AC6 Q40134053-3A6DFF14-2E3A-415B-90B6-8B4255E5DF38 Q40722407-F1714C5F-9443-48C8-BFDB-D953A96B9C3B Q41921198-D3AE70A0-F06F-46ED-A2F6-FF9EE0996FE6

P2860

Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen

http://www.wikidata.org/entity/Q34764532

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intradermal administration of ...... y to a co-administered antigen

@ast

Intradermal administration of ...... y to a co-administered antigen

@en

Intradermal administration of ...... y to a co-administered antigen

@nl

type

label

Intradermal administration of ...... y to a co-administered antigen

@ast

Intradermal administration of ...... y to a co-administered antigen

@en

Intradermal administration of ...... y to a co-administered antigen

@nl

prefLabel

Intradermal administration of ...... y to a co-administered antigen

@ast

Intradermal administration of ...... y to a co-administered antigen

@en

Intradermal administration of ...... y to a co-administered antigen

@nl

P1433

Q34764532-E4E5F7E3-6DE9-494F-AE5A-1A4B73A7614E

P1476

Q34764532-4B1AE544-0E87-4733-9910-A8165C04A03E

P2093

Q34764532-1441B360-A056-485E-9A6C-3EB43700E497

Q34764532-2B5FD1AB-816E-42C2-9631-0AEC7C533770

Q34764532-65B14B02-DE52-4535-A81E-8AC7D15A22DB

Q34764532-6C1E2659-6C4A-4C8D-BDDB-C4B08A173AAB

Q34764532-8864D27E-25DF-4675-A998-DEB926E14CA5

Q34764532-E119E479-EADF-4904-A2BE-615F3FA20546

P2860

Q34764532-1136A9AA-E911-4C6B-9AF2-B515E31E218F

Q34764532-1879B378-8CB0-4E72-8F67-B1AB9FF14A27

Q34764532-299E111B-9F13-4C64-9D38-DE02D41FC6EA

Q34764532-3262D6E1-4148-4196-AB7B-14B2C1AC1723

Q34764532-3349E75A-8731-4B35-8E89-4955798D1470

Q34764532-390091FA-094F-406A-B18C-802E0073BC4D

Q34764532-3D5426C5-2A39-4E47-AD48-D76BE49B2910

Q34764532-429A5BCB-74E2-44D6-9DAD-10B343A57009

Q34764532-4B852FED-54D7-43FC-889D-F9EEB01D18C3

Q34764532-5C71CA17-A953-4630-84FE-E744BDE286DD

P304

Q34764532-ADA8DCC8-FB0E-419D-A9D2-E18783A7C131

P31

Q34764532-B35C3E31-48A6-4ADA-974E-6CF0FD88E458

P356

Q34764532-1588B38C-BBAD-4582-B256-A55B6CFA91AF

P407

Q34764532-5084618E-D6EE-4162-ADAF-C9E4501A85C2

P433

Q34764532-322CF4CC-C8EA-4D3F-9736-2982748C53CE

P478

Q34764532-9674A65F-AC8F-4E04-82E1-D34375B38F61

P50

Q34764532-ACA6861B-7AFC-4B98-B5F5-765D25A439B9

Q34764532-DC1CB694-ABD0-4E9C-9554-02A7109C5EF7

P577

Q34764532-D4085BDE-9A1F-4523-9239-257F69BD3F94

P5875

Q34764532-C2705B6F-A119-4BBB-9AEE-FFE982E6C4BE

P698

Q34764532-055858D9-1445-473D-80D4-1B4319A59A9B

P932

Q34764532-40F33877-FA53-4BC6-BEAC-07D3E80EC725

P356

JOURNAL.PONE.0113978

P1433

P1476

Intradermal administration of ...... y to a co-administered antigen

@en

P2093

Camila Mathias-Santos

http://www.w3.org/2001/XMLSchema#string

Christopher J Greene

http://www.w3.org/2001/XMLSchema#string

John C Hu

http://www.w3.org/2001/XMLSchema#string

Juliana F Rodrigues

http://www.w3.org/2001/XMLSchema#string

Natalie D King-Lyons

http://www.w3.org/2001/XMLSchema#string

Terry D Connell

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine design for CD8 T lymphocyte responses

Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.

Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.

Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I)

Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb

Memory CD8 T-cell differentiation during viral infection.

Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine.

LT-IIc, a new member of the type II heat-labile enterotoxin family encoded by an Escherichia coli strain obtained from a nonmammalian host.

Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A

LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.

P304

e113978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0113978

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

George Hajishengallis

Luis Carlos de Souza Ferreira

P577

2014-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270054973

http://www.w3.org/2001/XMLSchema#string

P698

25536061

http://www.w3.org/2001/XMLSchema#string

P932

4275187

http://www.w3.org/2001/XMLSchema#string